Hangzhou Tangji Medical Technology Co.
Latest round
- Series C
Last raised
- Feb 2025
Total raised
- $22M
Investors
- 14
About Hangzhou Tangji Medical Technology Co.
,Ltd is a medical device for metabolic diseases developer. In March 2017, a sample of its Gastric Bypass Stent System was produced. In December 2018, the scientific and clinical research of Gastric Bypass Stent System was initiated. Its development of gastric bypass stent system was under the procedure of medical device inspection by National Medical Products Administration (NMPA) in August of 2020. In January 2021, the registered clinical trial of the Gastric Bypass Stent System was initiated. The company focuses on the treatment of metabolic diseases such as diabetes, obesity, and non-alcoholic fatty liver disease. The company's products can be categorized into gastric bypass stent systems and endoscopic interventional therapy products. Gastric bypass stent system can be used to control metabolic diseases, which contains advantages of being less invasive, and not damaging the human body structure. The company has dozens of R & D personnel, including one doctor and six masters. The company gained more than 20 patents all over the world. The company’s revenue is generated by providing gastrointestinal interventional therapy and related medical devices.
Who invested in Hangzhou Tangji Medical Technology Co.
14 investors across 8 rounds
See all investors in Hangzhou Tangji Medical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Feb 5, 2025
Amount
$14M
Investors
Series B
Aug 31, 2023
Amount
Undisclosed
Investors
Series B
Mar 23, 2023
Amount
Undisclosed
Investors
Series B
Jun 16, 2022
Amount
Undisclosed
Investors
Series C
May 11, 2021
Amount
$8.5M
Investors
Series B
Jul 30, 2019
Amount
Undisclosed
Investors
Series A
Jun 15, 2018
Amount
Undisclosed
Investors
Series A
Mar 22, 2018
Amount
Undisclosed
Investors
Questions about Hangzhou Tangji Medical Technology Co.
Who invested in Hangzhou Tangji Medical Technology Co.?
Hangzhou Tangji Medical Technology Co. has 14 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Tangji Medical Technology Co. raised?
Hangzhou Tangji Medical Technology Co. has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Hangzhou Tangji Medical Technology Co. last raise money?
Hangzhou Tangji Medical Technology Co.'s most recent round on record is a Series C, in Feb 2025.
What does Hangzhou Tangji Medical Technology Co. do?
,Ltd is a medical device for metabolic diseases developer.
Where is Hangzhou Tangji Medical Technology Co. headquartered?
Hangzhou Tangji Medical Technology Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Tangji Medical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Hangzhou Tangji Medical Technology Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Hangzhou Tangji Medical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.